Cover Image

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

SARS-CoV-2 has caused tens of thousands of infections and more than one thousand deaths. There are currently no registered therapies for treating coronavirus infections. Because of time consuming process of new drug development, drug repositioning may be the only solution to the epidemic of sudden i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Canrong Wu (Author), Yang Liu (Author), Yueying Yang (Author), Peng Zhang (Author), Wu Zhong (Author), Yali Wang (Author), Qiqi Wang (Author), Yang Xu (Author), Mingxue Li (Author), Xingzhou Li (Author), Mengzhu Zheng (Author), Lixia Chen (Author), Hua Li (Author)
Format:	Book
Published:	Elsevier, 2020-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Changes in the characteristics of dental emergencies under the influence of SARS-CoV-2 pandemic: a retrospective study
by: Kan Wu, et al.
Published: (2021)

The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer
by: Yang Liu, et al.
Published: (2023)

A study of breastfeeding practices, SARS-CoV-2 and its antibodies in the breast milk of mothers confirmed with COVID-19
by: Sicong Peng, et al.
Published: (2020)

The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
by: Binbin Xia, et al.
Published: (2023)

Application of PROTACs in target identification and validation
by: Yang Liu, et al.
Published: (2024)

Genomic characteristics of SARS-CoV-2 in Beijing, China, 2021
by: Zhaomin Feng, et al.
Published: (2022)

Importation of SARS-CoV-2 Omicron variant in Beijing, China
by: Fu Li, et al.
Published: (2022)

The SARS-CoV-2 vaccination rate and hesitation in Shanghai older adults with dementia
by: Yang Yang, et al.
Published: (2023)

The Emergence and Spread of Novel SARS-CoV-2 Variants
by: Huaimin Yi, et al.
Published: (2021)

Development and Validation of a Nomogram to Assist Monitoring Nosocomial SARS-CoV-2 Infection of Hospitalized Patients
by: Wang C, et al.
Published: (2022)

The differences in virus shedding time between the Delta variant and original SARS-CoV-2 infected patients
by: Fanglin Li, et al.
Published: (2023)

Children Infected With SARS-CoV-2 From Family Clusters
by: Dan Sun, et al.
Published: (2020)

Characterization of the gut microbiota in patients with SARS-CoV-2 infection during controlled ovarian stimulation
by: Tianjin Yang, et al.
Published: (2024)

Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 Mpro
by: Min Zhang, et al.
Published: (2023)

Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review
by: Lei Zhao, et al.
Published: (2022)

The analysis of characteristics of anti-SARS-CoV-2 antibodies in clinically COVID-19 patients
by: Wenzheng Guo, et al.
Published: (2020)

Investigating the impact of SARS-CoV-2 infection on basic semen parameters and in vitro fertilization/intracytoplasmic sperm injection outcomes: a retrospective cohort study
by: Meng Wang, et al.
Published: (2022)

Renal Injury by SARS-CoV-2 Infection: A Systematic Review
by: Mo Wang, et al.
Published: (2020)

PROTAC technology as a novel tool to identify the target of lathyrane diterpenoids
by: Yanli Wu, et al.
Published: (2022)

Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
by: Wu Zhong, et al.
Published: (2022)

Epidemiological characteristics of first-time SARS-CoV-2 Omicron infection among hospital staff in Chengdu, China
by: Li Tang, et al.
Published: (2024)

Vaccination and Government Stringent Control as Effective Strategies in Preventing SARS-CoV-2 Infections: A Global Perspective
by: Peng Yang, et al.
Published: (2022)

Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2
by: Haiyan Yan, et al.
Published: (2021)

Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular Dynamics Simulations, and Biological Evaluation
by: Xiaoyan Tian, et al.
Published: (2022)

Self-Reported adverse events among Chinese healthcare workers immunized with COVID-19 vaccines composed of inactivated SARS-CoV-2
by: Yandong Cheng, et al.
Published: (2022)

Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain
by: Xingsu Gao, et al.
Published: (2022)

Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugs
by: Wu Zhong, et al.
Published: (2022)

Evaluating the accessibility and capacity of SARS-CoV-2 vaccination and analyzing convenience-related factors during the Omicron variant epidemic in Beijing, China
by: Yuping Duan, et al.
Published: (2023)

Association Between SARS-CoV-2 Infection and Acute Ischemic Colitis
by: Wu Y, et al.
Published: (2024)

Dynamic Changes of Antibodies to SARS-CoV-2 in Close Contacts
by: Yao J, et al.
Published: (2021)

Computational strategies for PROTAC drug discovery
by: Jia Wu, et al.
Published: (2023)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023)

Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue
by: Zhonglei Wang, et al.
Published: (2022)

Prevention and Treatment of Skin Damage Caused by Personal Protective Equipment: Experience of the First-Line Clinicians Treating SARS-CoV-2 Infection
by: Nuo-Ya Zhou, et al.
Published: (2020)

Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation
by: Ting Xiao, et al.
Published: (2021)

Acute necrotizing encephalopathy caused by SARS-CoV-2 in a child
by: Po-Yuan Wang, et al.
Published: (2022)

Role of innate immunity in SARS-CoV-2 infection
by: Zihao Wang, et al.
Published: (2023)

Olmesartan alleviates SARS-CoV-2 envelope protein induced renal fibrosis by regulating HMGB1 release and autophagic degradation of TGF-β1
by: Shilin Zhou, et al.
Published: (2023)

Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2
by: Wei Chen, et al.
Published: (2021)

Epidemiological and Genomic Analysis of SARS-CoV-2 in 10 Patients From a Mid-Sized City Outside of Hubei, China in the Early Phase of the COVID-19 Outbreak
by: Jinkun Chen, et al.
Published: (2020)